ENSYSCE BIOSCIENCES, INC.: cashflow_financing
| Value | {"amount": 612862, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"} |
|---|---|
| Period | 2021-01-01 – 2021-03-31 |
| Status | current |
| Entity | ENSYSCE BIOSCIENCES, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:34:05.973304+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/5d8e54a8-f4b4-458b-bd96-ff6a7ed65336
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001493152-22-013083Retrieved: 2026-08-19T17:34:05.973304+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001716947/cashflow-financing/2021-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/5d8e54a8-f4b4-458b-bd96-ff6a7ed65336
History
- supersedes {"amount": 297500, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"} (evidence 0001493152-21-013768)